PharmaVantage is a full service company engaged in three
main business activities related to pharmaceutical
intermediates and APIs;
to China and
services. Our management has over twenty years of experience
in the pharmaceutical industry in China and has historic
relationships with manufacturers, distributors and
We have a core group of both Chinese and
overseas clientele and are seeking to expand our long-term
partnerships. We are more than a typical agent as our goal
is to enhance our clients business activities in China to
maximize the opportunities. Internationally we work with
major generic companies in the US, Europe and the Middle
East. In China we have collaborations with two R & D
facilities that assist in process development and process
optimization prior to scaling up in Chinese GMP compiant
factories. In China we work with several large successful
state-owned companies including Shijiazhuang Group, Shanghai
Pharma Group and Harbin Pharma Group as well as several
privately-owned companies such as the Hengdian Group, Excel
Pharmaceutical and Zhongdan Pharmaceutical.
Our sourcing activities include
development of key intermediates, custom manufacturing
projects both at the R and D and commercial level. We plan
to extend our activities in regulated markets by filing
several DMFs in the USA over the next two years.
Our sales activities include product
registration for sales to China, marketing and distribution
in China. We have fifteen years experience in registration.
Our consulting activities include
market/competitor intelligence and identification of
cooperative Chinese partners. We offer similar services to
our Chinese clients. Our director, Ms. Susan Capie has
extensive contacts both within China and abroad and is a
frequent speaker on the Chinese pharmaceutical industry and
has authored numerous articles on this topic.
There are currently over 5,000 Chinese
manufacturers and identifying the best partner/supplier is a
lengthy process. PharmaVantage can assist you in finding the
best partner/strategy to maximize the opportunities in the
Chinese pharmaceutical industry in both sourcing from and
selling to China. Relationships, language and cultural
familiarity are essential to success in China and with our
extensive ties and long involvement we can be of invaluable
assistance to clients.
The Chinese pharmaceutical
industry is currently undergoing rapid changes and
consolidations, mergers and acquisitions, privatization. It
is essential for success in China to have a solid channel to
suppliers to support the customers? success in China and to
minimize the problems. Given China's rising importance as a
pharma supplier, for most companies, the question is not
if you should be involved in China, but how
to develop a successful strategy. PharmaVantage can provide
our clients' opportunities through leveraging our knowledge
and experience. In the current challenging,
ever-changing pharmaceutical landscape, we all share a
common goal-low cost, effective products for our markets.
clients are seeking long-term strategic partnerships abroad.
Our foreign clients are seeking the same but the
difficulties of language, culture, and size of the market is
often a barrier. The difficulties of evaluating the
multitude of Chinese suppliers is daunting and time
consuming. We offer a channel to understand the
regulatory and economic environment and a conduit to
partnerships in China.
key executives began business relations in the
pharmaceutical area in 1984. Our long-standing relationships
with manufacturers and relevant government agencies include
key decision-makers, R and D departments, QA and sales.
Our non-Chinese clientele include multi-national
pharmaceutical companies as well as leading generic firms in
the USA, Europe, Middle East and South America.
China is increasingly important as a supply
source of APIs and intermediates. China has more than 5000
pharma/chemical companies and a large number of trading
companies, distributors and agents. Currently China's
pharmaceutical industry is undergoing profound changes,
which makes it difficult for foreign companies to obtain the
most up-to-date information. With our broad network,
knowledge and twenty years of business history, we are well
placed to assist companies in this challenging but exciting
marketplace in China